United States Sulphonamides Market Report 2017

United States Sulphonamides Market Report 2017

1 Sulphonamides Overview

1.1 Product Overview and Scope of Sulphonamides

1.2 Classification of Sulphonamides

1.2.1 Orally Absorbable Sulfonamide

1.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

1.2.3 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)

1.3 Application of Sulphonamides

1.3.1 Skin Infections

1.3.2 Gastro Intestinal Tract (GIT) Infection

1.3.3 Meningitis

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Sulphonamides (2012-2022)

1.4.1 United States Sulphonamides Sales and Growth Rate (2012-2022)

1.4.2 United States Sulphonamides Revenue and Growth Rate (2012-2022)

2 United States Sulphonamides Competition by Manufacturers

2.1 United States Sulphonamides Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Sulphonamides Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Sulphonamides Average Price by Manufactures (2015 and 2016)

2.4 Sulphonamides Market Competitive Situation and Trends

2.4.1 Sulphonamides Market Concentration Rate

2.4.2 Sulphonamides Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Sulphonamides Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Sulphonamides Sales and Market Share by States (2012-2017)

3.2 United States Sulphonamides Revenue and Market Share by States (2012-2017)

3.3 United States Sulphonamides Price by States (2012-2017)

4 United States Sulphonamides Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Sulphonamides Sales and Market Share by Type (2012-2017)

4.2 United States Sulphonamides Revenue and Market Share by Type (2012-2017)

4.3 United States Sulphonamides Price by Type (2012-2017)

4.4 United States Sulphonamides Sales Growth Rate by Type (2012-2017)

5 United States Sulphonamides Sales (Volume) by Application (2012-2017)

5.1 United States Sulphonamides Sales and Market Share by Application (2012-2017)

5.2 United States Sulphonamides Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Sulphonamides Manufacturers Profiles/Analysis

6.1 Abbott Laboratories

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Sulphonamides Product Type, Application and Specification

6.1.2.1 Orally Absorbable Sulfonamide

6.1.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

6.1.3 Abbott Laboratories Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Boehringer Ingelheim Pharmaceuticals

6.2.2 Sulphonamides Product Type, Application and Specification

6.2.2.1 Orally Absorbable Sulfonamide

6.2.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

6.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Bayer AG

6.3.2 Sulphonamides Product Type, Application and Specification

6.3.2.1 Orally Absorbable Sulfonamide

6.3.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

6.3.3 Bayer AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 GlaxoSmithKline

6.4.2 Sulphonamides Product Type, Application and Specification

6.4.2.1 Orally Absorbable Sulfonamide

6.4.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

6.4.3 GlaxoSmithKline Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 King Pharmaceuticals

6.5.2 Sulphonamides Product Type, Application and Specification

6.5.2.1 Orally Absorbable Sulfonamide

6.5.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

6.5.3 King Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Mylan Pharmaceuticals

6.6.2 Sulphonamides Product Type, Application and Specification

6.6.2.1 Orally Absorbable Sulfonamide

6.6.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

6.6.3 Mylan Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Novartis International AG

6.7.2 Sulphonamides Product Type, Application and Specification

6.7.2.1 Orally Absorbable Sulfonamide

6.7.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

6.7.3 Novartis International AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Pfizer

6.8.2 Sulphonamides Product Type, Application and Specification

6.8.2.1 Orally Absorbable Sulfonamide

6.8.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

6.8.3 Pfizer Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Par Pharmaceutical

6.9.2 Sulphonamides Product Type, Application and Specification

6.9.2.1 Orally Absorbable Sulfonamide

6.9.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

6.9.3 Par Pharmaceutical Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Roche Holding AG

6.10.2 Sulphonamides Product Type, Application and Specification

6.10.2.1 Orally Absorbable Sulfonamide

6.10.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

6.10.3 Roche Holding AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Sanofi Aventis

6.12 Stiefel Laboratories

7 Sulphonamides Manufacturing Cost Analysis

7.1 Sulphonamides Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Sulphonamides

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Sulphonamides Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Sulphonamides Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Sulphonamides Market Forecast (2017-2022)

11.1 United States Sulphonamides Sales, Revenue Forecast (2017-2022)

11.2 United States Sulphonamides Sales Forecast by Type (2017-2022)

11.3 United States Sulphonamides Sales Forecast by Application (2017-2022)

11.4 Sulphonamides Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Sulphonamides

Table Classification of Sulphonamides

Figure United States Sales Market Share of Sulphonamides by Type in 2015

Figure Orally Absorbable Sulfonamide Picture

Figure Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Picture

Figure Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Picture

Table Application of Sulphonamides

Figure United States Sales Market Share of Sulphonamides by Application in 2015

Figure Skin Infections Examples

Figure Gastro Intestinal Tract (GIT) Infection Examples

Figure Meningitis Examples

Figure United States Sulphonamides Sales and Growth Rate (2012-2022)

Figure United States Sulphonamides Revenue and Growth Rate (2012-2022)

Table United States Sulphonamides Sales of Key Manufacturers (2015 and 2016)

Table United States Sulphonamides Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Sulphonamides Sales Share by Manufacturers

Figure 2016 Sulphonamides Sales Share by Manufacturers

Table United States Sulphonamides Revenue by Manufacturers (2015 and 2016)

Table United States Sulphonamides Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Sulphonamides Revenue Share by Manufacturers

Table 2016 United States Sulphonamides Revenue Share by Manufacturers

Table United States Market Sulphonamides Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Sulphonamides Average Price of Key Manufacturers in 2015

Figure Sulphonamides Market Share of Top 3 Manufacturers

Figure Sulphonamides Market Share of Top 5 Manufacturers

Table United States Sulphonamides Sales by States (2012-2017)

Table United States Sulphonamides Sales Share by States (2012-2017)

Figure United States Sulphonamides Sales Market Share by States in 2015

Table United States Sulphonamides Revenue and Market Share by States (2012-2017)

Table United States Sulphonamides Revenue Share by States (2012-2017)

Figure Revenue Market Share of Sulphonamides by States (2012-2017)

Table United States Sulphonamides Price by States (2012-2017)

Table United States Sulphonamides Sales by Type (2012-2017)

Table United States Sulphonamides Sales Share by Type (2012-2017)

Figure United States Sulphonamides Sales Market Share by Type in 2015

Table United States Sulphonamides Revenue and Market Share by Type (2012-2017)

Table United States Sulphonamides Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Sulphonamides by Type (2012-2017)

Table United States Sulphonamides Price by Type (2012-2017)

Figure United States Sulphonamides Sales Growth Rate by Type (2012-2017)

Table United States Sulphonamides Sales by Application (2012-2017)

Table United States Sulphonamides Sales Market Share by Application (2012-2017)

Figure United States Sulphonamides Sales Market Share by Application in 2015

Table United States Sulphonamides Sales Growth Rate by Application (2012-2017)

Figure United States Sulphonamides Sales Growth Rate by Application (2012-2017)

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Abbott Laboratories Sulphonamides Sales Market Share (2012-2017)

Table Boehringer Ingelheim Pharmaceuticals Basic Information List

Table Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

Table Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales Market Share (2012-2017)

Table Bayer AG Basic Information List

Table Bayer AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bayer AG Sulphonamides Sales Market Share (2012-2017)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

Table GlaxoSmithKline Sulphonamides Sales Market Share (2012-2017)

Table King Pharmaceuticals Basic Information List

Table King Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

Table King Pharmaceuticals Sulphonamides Sales Market Share (2012-2017)

Table Mylan Pharmaceuticals Basic Information List

Table Mylan Pharmaceuticals Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

Table Mylan Pharmaceuticals Sulphonamides Sales Market Share (2012-2017)

Table Novartis International AG Basic Information List

Table Novartis International AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis International AG Sulphonamides Sales Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pfizer Sulphonamides Sales Market Share (2012-2017)

Table Par Pharmaceutical Basic Information List

Table Par Pharmaceutical Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

Table Par Pharmaceutical Sulphonamides Sales Market Share (2012-2017)

Table Roche Holding AG Basic Information List

Table Roche Holding AG Sulphonamides Sales, Revenue, Price and Gross Margin (2012-2017)

Table Roche Holding AG Sulphonamides Sales Market Share (2012-2017)

Table Sanofi Aventis Basic Information List

Table Stiefel Laboratories Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Sulphonamides

Figure Manufacturing Process Analysis of Sulphonamides

Figure Sulphonamides Industrial Chain Analysis

Table Raw Materials Sources of Sulphonamides Major Manufacturers in 2015

Table Major Buyers of Sulphonamides

Table Distributors/Traders List

Figure United States Sulphonamides Production and Growth Rate Forecast (2017-2022)

Figure United States Sulphonamides Revenue and Growth Rate Forecast (2017-2022)

Table United States Sulphonamides Production Forecast by Type (2017-2022)

Table United States Sulphonamides Consumption Forecast by Application (2017-2022)

Table United States Sulphonamides Sales Forecast by States (2017-2022)

Table United States Sulphonamides Sales Share Forecast by States (2017-2022)